Laura Leigh Oyler
Laura Leigh trained as a lawyer and has spent the last 15+ years advocating globally for tobacco harm reduction policy. She led company preparations for two Tobacco Products Scientific Advisory Committee meetings on snus (Camel Snus in 2018 and General Snus' claim renewal in 2024), before starting at Nicokick as our VP of Regulatory Affairs.
It's been a big year for nicotine pouches. We look back at some of the regulatory milestones over the last 12 months, setting us up for an even stronger 2026.
We've just submitted a public comment in support of the FDA’s review of ZYN nicotine pouches under the Modified Risk Tobacco Product pathway.
Our Head of Regulatory Affairs shares her key takeaways from the Food & Drug Law Institute's annual tobacco conference for 2025.
Recent moves by the FDA signal greater collaboration between regulators, manufacturers, and retailers to build a more sustainable smokeless category—something we fully support.
There are a few key terms to be aware of when it comes to the FDA's regulation of nicotine pouches in the US. We break them down in this easy-to-understand guide.
A new AEI report challenges common myths about nicotine. Explore why smoke—not nicotine—is the real concern, and how smarter regulation could bring clarity.
Login and Registration Form